MyChesCo on MSN6h
INOVIO Reports Groundbreaking Results in COVID-19 Antibody TrialINOVIO (NASDAQ: INO) has announced notable interim findings from a Phase 1 clinical trial testing DNA-encoded monoclonal ...
MyChesCo on MSN10h
INOVIO to Announce Q4 and Year-End 2024 Results on March 18, 2025INOVIO (NASDAQ: INO) has announced that it will release its fourth-quarter and year-end 2024 financial results on March 18, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback